James M Foran

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi request reprint Frontline Therapy of AML: Should the Older Patient be Treated Differently?
    James M Foran
    Mayo Clinic Cancer Center, Division of Hematology and Medical Oncology, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL, 32224, USA
    Curr Hematol Malig Rep 9:100-8. 2014
  2. doi request reprint Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes
    James M Foran
    Mayo Clinic, Jacksonville, Florida 32224, USA
    Am J Med 125:S6-13. 2012
  3. doi request reprint Targeted therapy of acute myeloid leukemia in 2012: towards individualized therapy
    James M Foran
    Department of Internal Medicine, Division of Hematology Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, USA
    Hematology 17:S137-40. 2012

Detail Information

Publications3

  1. ncbi request reprint Frontline Therapy of AML: Should the Older Patient be Treated Differently?
    James M Foran
    Mayo Clinic Cancer Center, Division of Hematology and Medical Oncology, Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL, 32224, USA
    Curr Hematol Malig Rep 9:100-8. 2014
    ..It is critical that we support well-designed clinical trials to develop more effective frontline therapies, develop more informative biomarkers, and to better understand who is a candidate for curative treatment. ..
  2. doi request reprint Clinical presentation, diagnosis, and prognosis of myelodysplastic syndromes
    James M Foran
    Mayo Clinic, Jacksonville, Florida 32224, USA
    Am J Med 125:S6-13. 2012
    ..Patients with pancytopenia, bicytopenia, or any persistent and unexplained isolated cytopenia (and particularly unexplained macrocytic anemia) should be referred to a specialist to establish a diagnosis...
  3. doi request reprint Targeted therapy of acute myeloid leukemia in 2012: towards individualized therapy
    James M Foran
    Department of Internal Medicine, Division of Hematology Oncology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, USA
    Hematology 17:S137-40. 2012
    ..We are advancing towards an era of personalized medicine in AML, and can now better identify specific patients who may benefit from specific therapies with less toxicity...